DNA Vaccine Coding for the Rhesus Prostate Specific Antigen (rhPSA) and Electroporation in Patients With Relapsed Prostate Cancer. A Phase I/II Study.
Phase of Trial: Phase I/II
Latest Information Update: 09 May 2014
At a glance
- Drugs Prostate cancer DNA vaccine (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 07 Jun 2017 Biomarkers information updated
- 14 Jul 2013 Status changed from recruiting to completed.
- 10 Mar 2009 Identified and added actual start date December 2008 and estimated end date September 2011 from ClinicalTrials.gov.